SCHEMBL5159055

SCHEMBL5159055

CC(C)(C)[Si](C)(C)Oc1cc(O)cc2c1[C@H]1CC[C@]3(C)CCC[C@H]3[C@@H]1CC2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SHBG P04278 3/20 0.54
STS P08842 5/20 0.41
HSD17B1 P14061 4/20 0.38
ESR1 P03372 7/20 0.37
LMNA P02545 5/20 0.37
HSD17B10 Q99714 4/20 0.37
ESR2 Q92731 4/20 0.37
CYP3A4 P08684 4/20 0.37
PGR P06401 3/20 0.37
AR P10275 3/20 0.37
MAPT P10636 3/20 0.37
TSHR P16473 2/20 0.37
CYP1A2 P05177 2/20 0.37
HIF1A Q16665 2/20 0.37
AKR1B10 O60218 2/20 0.37
SERPINA6 P08185 2/20 0.37
AKR1B1 P15121 2/20 0.37
SLC6A4 P31645 2/20 0.37
SNCA P37840 2/20 0.37
HTR2B P41595 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10439848 0.80 SHBG (0.65) SHBGSTSHSD17B1ESR1LMNA
SCHEMBL8409463 0.79 SHBG (0.45) SHBGSTSHSD17B1ESR1LMNA
SCHEMBL7163758 0.78 SHBG (0.66) SHBGSTSHSD17B1ESR1LMNA
SCHEMBL8409776 0.76 STS (0.40) SHBGSTSHSD17B1ESR1LMNA
SCHEMBL31185604 0.76 STS (0.65) SHBGSTSHSD17B1ESR1LMNA
SCHEMBL6866101 0.74 STS (0.49) SHBGSTSHSD17B1ESR1LMNA
SCHEMBL8571107 0.72 SHBG (0.60) SHBGSTSHSD17B1ESR1LMNA
SCHEMBL3974231 0.72 SHBG (0.57) SHBGSTSHSD17B1ESR1LMNA
SCHEMBL7864592 0.71 SHBG (1.00) SHBGSTSHSD17B1ESR1LMNA
SCHEMBL712443 0.71 SHBG (1.00) SHBGSTSHSD17B1ESR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1405860-B1 Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use STANFORD RES INST INT (US) 2007-02-14 EP disclosed
EP-1405860-A1 Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use SRI INTERNATIONAL (US) 2004-04-07 EP disclosed
US-6046186-A ANTITUMOR AGENTS, ANTICARCINOGENIC AGENTS SRI INTERNATIONAL (US) 2000-04-04 US disclosed
WO-1999033858-A9 ESTRONE SULFAMATE INHIBITORS OF ESTRONE SULFATASE, AND ASSOCIATED PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE STANFORD RES INST INT (US) 1999-10-28 WO disclosed